IDORSIA PHARMACEUTICALS UK LIMITED
Company number 13515638
- Company Overview for IDORSIA PHARMACEUTICALS UK LIMITED (13515638)
- Filing history for IDORSIA PHARMACEUTICALS UK LIMITED (13515638)
- People for IDORSIA PHARMACEUTICALS UK LIMITED (13515638)
- More for IDORSIA PHARMACEUTICALS UK LIMITED (13515638)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
25 Oct 2023 | AA | Accounts for a small company made up to 31 December 2022 | |
21 Aug 2023 | CS01 | Confirmation statement made on 15 July 2023 with no updates | |
22 Jun 2023 | AP01 | Appointment of Isabelle Mamet as a director on 21 June 2023 | |
21 Jun 2023 | AP01 | Appointment of Peter Graham as a director on 21 June 2023 | |
21 Jun 2023 | AP01 | Appointment of Alistair Paice as a director on 21 June 2023 | |
07 Sep 2022 | CS01 | Confirmation statement made on 15 July 2022 with updates | |
07 Jul 2022 | AA01 | Current accounting period extended from 31 December 2021 to 31 December 2022 | |
01 Jun 2022 | SH01 |
Statement of capital following an allotment of shares on 1 June 2022
|
|
12 Nov 2021 | AA01 | Current accounting period shortened from 31 July 2022 to 31 December 2021 | |
12 Nov 2021 | AD01 | Registered office address changed from 33 st James's Square London SW1Y 4JS to 20 Eastbourne Terrace London W2 6LG on 12 November 2021 | |
21 Sep 2021 | TM01 | Termination of appointment of Arno Groenewoud as a director on 13 September 2021 | |
21 Sep 2021 | AP01 | Appointment of Robert Justin Moore as a director on 13 September 2021 | |
16 Jul 2021 | NEWINC |
Incorporation
Statement of capital on 2021-07-16
|